Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CACTUS-PTS: Nadroparin for Distal DVT
NCT00421538Phase 3Completed
- Start
- Jan 2008
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in distal deep vein thrombosis comparing LMWH with Placebo (2 arms). Primary endpoints: Composite of rate of extension of distal DVT to proximal deep veins or symptomatic PE at 6 weeks and Rate of post-thrombotic syndrome (PTS) at 1 year. Started Jan 2008; status: completed.
02
Drugs
nadroparin
03
Conditions
distal deep vein thrombosis
Beyond the preview
Go deeper on NCT00421538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421538.